Dr. Tareq Al Baghdadi
Claim this profileGenesys Hurley Cancer Institute
Expert in Cancer
Expert in Pancreatic Cancer
73 reported clinical trials
130 drugs studied
About Tareq Al Baghdadi
Education:
- Earned a Medical Degree (MD) from an unspecified medical school.
- Completed a Residency in Internal Medicine at Saint Joseph Mercy Hospital, also serving as Chief Resident.
- Undertook a Fellowship in Cardiovascular Disease at Saint Joseph Mercy Hospital.
Experience:
- N/A
Area of expertise
1Cancer
Global LeaderStage IV
KRAS positive
Stage III
2Pancreatic Cancer
Global LeaderStage IV
KRAS positive
Stage III
Affiliated Hospitals
Clinical Trials Tareq Al Baghdadi is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
More about Tareq Al Baghdadi
Clinical Trial Related8 years of experience running clinical trials · Led 73 trials as a Principal Investigator · 29 Active Clinical TrialsTreatments Tareq Al Baghdadi has experience with
- Pembrolizumab
- Atezolizumab
- Cisplatin
- Nivolumab
- Fluorouracil
- Carboplatin
Breakdown of trials Tareq Al Baghdadi has run
Cancer
Pancreatic Cancer
Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tareq Al Baghdadi specialize in?
Tareq Al Baghdadi focuses on Cancer and Pancreatic Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Tareq Al Baghdadi currently recruiting for clinical trials?
Yes, Tareq Al Baghdadi is currently recruiting for 29 clinical trials in Flint Michigan. If you're interested in participating, you should apply.
Are there any treatments that Tareq Al Baghdadi has studied deeply?
Yes, Tareq Al Baghdadi has studied treatments such as Pembrolizumab, Atezolizumab, Cisplatin.
What is the best way to schedule an appointment with Tareq Al Baghdadi?
Apply for one of the trials that Tareq Al Baghdadi is conducting.
What is the office address of Tareq Al Baghdadi?
The office of Tareq Al Baghdadi is located at: Genesys Hurley Cancer Institute, Flint, Michigan 48503 United States. This is the address for their practice at the Genesys Hurley Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.